[Diseases of the cornea].
Explore the source record for details and available documents.
Anti-Infective Agents↗
Biomedical subjects
P U Fechner
Publications and source records attributed to P U Fechner.
[Inflammations of the uvea and retina].
Explore the source record for details and available documents.
Adult↗
[Inflmmation of sclera].
Explore the source record for details and available documents.
Administration, Topical↗
[Diseases caused by animal parasitesi zoonoses].
Explore the source record for details and available documents.
Animals↗
[Injuries, burns, poisonings].
Explore the source record for details and available documents.
Eye Burns↗
[Eye lesions caused by systemically administered drugs].
Explore the source record for details and available documents.
Analgesics↗
[Ophthalmologic mycology and antimycotics].
Explore the source record for details and available documents.
Antifungal Agents↗
[Chemotherapy of virus infections].
Explore the source record for details and available documents.
Antiviral Agents↗
[Corticosteroids].
Explore the source record for details and available documents.
Adrenal Cortex Hormones↗
[Cytostatic and immunosuppressive agents].
Explore the source record for details and available documents.
Antineoplastic Agents↗
[Drugs affecting blood coagulation. Hemostyptic agents].
Explore the source record for details and available documents.
Eye Diseases↗
[Pharmacological principles of glaucoma therapyAQ].
Explore the source record for details and available documents.
Glaucoma↗
Glaucoma operation with the argon laser.
Explore the source record for details and available documents.
Argon↗
[Non-inflammatory diseases of the retina].
Explore the source record for details and available documents.
Adult↗
Accommodative effects of aceclidine in the treatment of glaucoma.
In 18 patients, 2% pilocarpine, 2% pilocarpine plus tropicamide 10:1, and 2% aceclidine were tested with respect to the degree of spasm of accommodation induced by these drugs. Aceclidine had the least effect on accommodation, making it the recommended drug for use in patients with glaucoma and considerable remaining accommodation, i.e., most patients under the age of 50 years.
Accommodation, Ocular↗